BACKGROUND: myocardial lipid accumulation precedes some cardiomyopathies, but little is known of concurrent effects on ventricular mechanics. We tested the hypothesis that intramyocardial lipid accumulation during a short-term, high-fat diet (HFD) affects 2-dimensional strains in the heart. We examined the hearts of nontransgenic (NTG) mice and of transgenic mice predisposed to elevated triacylglyceride (TAG) storage linked to low-level overexpression of peroxisome proliferator activated receptor (PPAR-α). METHODS AND RESULTS: myocardial lipid and transmural principal strains E1 and E2 were determined in vivo with (1)H magnetic resonance spectroscopy/imaging before and after 2 weeks of an HFD in both PPAR-α and NTG littermate mice. Baseline lipid was elevated in PPAR-α compared with NTG mice. An HFD increased mobile lipid by 174% in NTG mice (P<0.05) and by 79% in PPAR-α mice (P<0.05). After an HFD, lipid and TAG were higher in PPAR-α versus NTG mice by 63% and 81%, respectively. However, TAG in PPAR-α mice after an HFD was similar to TAG in PPAR-α mice fed a regular diet, suggesting that the magnetic resonance spectroscopy signal from lipid is not exclusive to TAG. Only at the highest lipid contents, achieved in PPAR-α mice, were strains affected. Endocardial strain was most compromised, with a negative correlation to lipid (P<0.05). CONCLUSIONS: a short-term HFD elevated myocardial lipid measures as determined by magnetic resonance spectroscopy, which became dissociated from TAG content in hearts predisposed to cardiac steatosis. The increased lipid was associated with concurrent, transmural reductions in E1 and E2 strains across the left ventricular wall. Strains were attenuated at the highest levels of lipid accumulation, suggesting a threshold response. Thus, 2-dimensional strains are impaired early and without left ventricular diastolic dysfunction, owing to cardiac steatosis.
BACKGROUND: myocardial lipid accumulation precedes some cardiomyopathies, but little is known of concurrent effects on ventricular mechanics. We tested the hypothesis that intramyocardial lipid accumulation during a short-term, high-fat diet (HFD) affects 2-dimensional strains in the heart. We examined the hearts of nontransgenic (NTG) mice and of transgenic mice predisposed to elevated triacylglyceride (TAG) storage linked to low-level overexpression of peroxisome proliferator activated receptor (PPAR-α). METHODS AND RESULTS: myocardial lipid and transmural principal strains E1 and E2 were determined in vivo with (1)H magnetic resonance spectroscopy/imaging before and after 2 weeks of an HFD in both PPAR-α and NTG littermate mice. Baseline lipid was elevated in PPAR-α compared with NTGmice. An HFD increased mobile lipid by 174% in NTGmice (P<0.05) and by 79% in PPAR-α mice (P<0.05). After an HFD, lipid and TAG were higher in PPAR-α versus NTGmice by 63% and 81%, respectively. However, TAG in PPAR-α mice after an HFD was similar to TAG in PPAR-α mice fed a regular diet, suggesting that the magnetic resonance spectroscopy signal from lipid is not exclusive to TAG. Only at the highest lipid contents, achieved in PPAR-α mice, were strains affected. Endocardial strain was most compromised, with a negative correlation to lipid (P<0.05). CONCLUSIONS: a short-term HFD elevated myocardial lipid measures as determined by magnetic resonance spectroscopy, which became dissociated from TAG content in hearts predisposed to cardiac steatosis. The increased lipid was associated with concurrent, transmural reductions in E1 and E2 strains across the left ventricular wall. Strains were attenuated at the highest levels of lipid accumulation, suggesting a threshold response. Thus, 2-dimensional strains are impaired early and without left ventricular diastolic dysfunction, owing to cardiac steatosis.
Authors: Brian N Finck; John J Lehman; Teresa C Leone; Michael J Welch; Michael J Bennett; Attila Kovacs; Xianlin Han; Richard W Gross; Ray Kozak; Gary D Lopaschuk; Daniel P Kelly Journal: J Clin Invest Date: 2002-01 Impact factor: 14.808
Authors: Jason S Reingold; Jonathan M McGavock; Shaheen Kaka; Tommy Tillery; Ronald G Victor; Lidia S Szczepaniak Journal: Am J Physiol Endocrinol Metab Date: 2005-06-21 Impact factor: 4.310
Authors: Hildo J Lamb; Johannes Wa Smit; Rutger W van der Meer; Sebastiaan Hammer; Joost Doornbos; Albert de Roos; Johannes A Romijn Journal: Curr Opin Clin Nutr Metab Care Date: 2008-09 Impact factor: 4.294
Authors: Janusz H Hankiewicz; Paul H Goldspink; Peter M Buttrick; E Douglas Lewandowski Journal: Am J Physiol Heart Circ Physiol Date: 2007-10-26 Impact factor: 4.733
Authors: Janet Wei; Michael D Nelson; Edward W Szczepaniak; Laura Smith; Puja K Mehta; Louise E J Thomson; Daniel S Berman; Debiao Li; C Noel Bairey Merz; Lidia S Szczepaniak Journal: Am J Physiol Heart Circ Physiol Date: 2015-10-30 Impact factor: 4.733
Authors: Heinrich Taegtmeyer; Martin E Young; Gary D Lopaschuk; E Dale Abel; Henri Brunengraber; Victor Darley-Usmar; Christine Des Rosiers; Robert Gerszten; Jan F Glatz; Julian L Griffin; Robert J Gropler; Hermann-Georg Holzhuetter; Jorge R Kizer; E Douglas Lewandowski; Craig R Malloy; Stefan Neubauer; Linda R Peterson; Michael A Portman; Fabio A Recchia; Jennifer E Van Eyk; Thomas J Wang Journal: Circ Res Date: 2016-03-24 Impact factor: 17.367
Authors: Chehade N Karam; Chad M Warren; Marcus Henze; Natasha H Banke; E Douglas Lewandowski; R John Solaro Journal: Am J Physiol Heart Circ Physiol Date: 2017-01-27 Impact factor: 4.733
Authors: Euy-Myoung Jeong; Jaehoon Chung; Hong Liu; Yeongju Go; Scott Gladstein; Afshin Farzaneh-Far; E Douglas Lewandowski; Samuel C Dudley Journal: J Am Heart Assoc Date: 2016-05-05 Impact factor: 5.501
Authors: Ira J Goldberg; Karen Reue; Nada A Abumrad; Perry E Bickel; Sarah Cohen; Edward A Fisher; Zorina S Galis; James G Granneman; E Douglas Lewandowski; Robert Murphy; Michelle Olive; Jean E Schaffer; Lisa Schwartz-Longacre; Gerald I Shulman; Tobias C Walther; Jue Chen Journal: Circulation Date: 2018-07-17 Impact factor: 29.690